Charles Quesenberry to Postmenopause
This is a "connection" page, showing publications Charles Quesenberry has written about Postmenopause.
Connection Strength
0.341
-
Reduced mortality associated with long-term postmenopausal estrogen therapy. Obstet Gynecol. 1996 Jan; 87(1):6-12.
Score: 0.120
-
Re: Declines in invasive breast cancer and use of postmenopausal hormone therapy in a screening mammography population. J Natl Cancer Inst. 2008 Apr 16; 100(8):597-8; author reply 599.
Score: 0.070
-
Hormone replacement therapy and the risk of myocardial infarction in women with coronary risk factors. Epidemiology. 2000 Sep; 11(5):603-6.
Score: 0.041
-
Changes in bone mineral density in women with breast cancer receiving aromatase inhibitor therapy. Breast Cancer Res Treat. 2018 Apr; 168(2):523-530.
Score: 0.034
-
Myocardial infarction and the use of estrogen and estrogen-progestogen in postmenopausal women. Ann Intern Med. 1997 Oct 01; 127(7):501-8.
Score: 0.034
-
Timing of hormone therapy and dementia: the critical window theory revisited. Ann Neurol. 2011 Jan; 69(1):163-9.
Score: 0.021
-
Hormone replacement therapy and risk for foot, distal forearm, proximal humerus, and pelvis fractures. Osteoporos Int. 2003 Jul; 14(6):469-75.
Score: 0.012
-
Ischemic stroke and use of estrogen and estrogen/progestogen as hormone replacement therapy. Stroke. 1998 Jan; 29(1):23-8.
Score: 0.009